On 6/3/24, Novavax Inc (NASDAQ: NVAX) stock enjoyed a major increase of 21.2%, closing at $18.22. Moreover, unusually high trading volume at 192% of normal accompanied the advance. Relative to the market the stock has been weak over the last nine months but has risen 20.3% during the last week.
Current PriceTarget Research Rating
NVAX’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to continue to be a major Value Eraser.
Novavax is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment